Skip to content

How much does riluzole cost for ALS? A 2025 Price Analysis

4 min read

Riluzole was the first drug approved by the FDA to treat amyotrophic lateral sclerosis (ALS) [1.7.3]. For patients and their families, a primary concern is understanding the financial aspect of this treatment, specifically: How much does riluzole cost for ALS?

Quick Summary

A detailed look at the 2025 costs for different forms of riluzole for ALS, including generic tablets and brand names like Rilutek, Tiglutik, and Exservan. It covers price-influencing factors and financial aid options.

Key Points

  • Generic is Cheapest: Generic riluzole tablets are the most affordable option, often costing less than $40 per month with discount cards [1.2.2, 1.3.2].

  • Formulation Drives Price: Liquid (Tiglutik) and oral film (Exservan) versions cost thousands of dollars per month but are designed for patients with swallowing difficulties [1.4.2, 1.2.4].

  • Insurance is Crucial: Out-of-pocket costs are primarily determined by the patient's insurance plan, as coverage for different riluzole forms varies widely [1.9.1, 1.9.4].

  • Assistance is Available: Patient Assistance Programs (PAPs) from drug manufacturers and grants from non-profits like The ALS Association can significantly lower costs [1.5.4, 1.10.1].

  • Shop Around: The price for generic riluzole can differ significantly between pharmacies; using discount cards can result in savings of over 95% [1.2.1, 1.3.2].

In This Article

What is Riluzole and How Does It Help in ALS?

Riluzole is a medication used to treat amyotrophic lateral sclerosis, also known as Lou Gehrig's disease [1.2.1]. It is believed to work by reducing damage to motor neurons through decreasing the release of glutamate, a chemical messenger in the brain [1.7.3]. While it does not cure ALS or reverse existing nerve damage, clinical trials have shown that riluzole can prolong survival by several months and extend the time before a patient requires ventilator support [1.7.2, 1.7.3]. It is the first treatment that was approved by the FDA for this condition, marking a significant step in managing the disease's progression [1.7.5]. The medication is available in several forms to accommodate patient needs, including standard tablets, a liquid suspension, and an oral film [1.7.1].

Efficacy and Common Side Effects

The primary benefit of riluzole is its ability to slow the progression of ALS [1.7.2]. While initial trials suggested a survival benefit of about three months, more recent data indicates it could be as much as 12 months [1.7.2]. Common side effects can include nausea, weakness, dizziness, and stomach pain [1.8.1, 1.8.2]. It is also important for patients to have their liver function monitored through blood tests, as liver damage is a potential serious side effect [1.8.1, 1.8.4]. Other serious but less common side effects may include low white blood cell counts (neutropenia) and lung inflammation [1.8.1, 1.8.4].

A Detailed Breakdown of Riluzole Costs

The cost of riluzole varies dramatically depending on the formulation, whether it is a brand name or generic, the pharmacy, and the patient's insurance coverage. Without insurance, the price differences are stark.

Generic vs. Brand-Name Tablets (Rilutek)

The most affordable option is the generic riluzole tablet. Using prescription discount cards, a month's supply (60 tablets of 50mg) can cost as little as $23 to $35 [1.2.1, 1.2.2]. The average retail price without discounts can be over $900, highlighting the significant savings available through discount programs [1.3.1]. In contrast, the brand name Rilutek, while chemically identical, carries a much higher price tag.

Alternative Formulations: Tiglutik and Exservan

For ALS patients who have difficulty swallowing (dysphagia), alternative formulations are available, but they come at a premium price.

  • Tiglutik: This is an oral suspension (liquid) form of riluzole [1.7.1]. Its cost can be substantial, with retail prices potentially reaching over $4,000 for a month's supply, though discount programs can lower this to under $3,000 [1.4.2]. The thickened liquid is easier for some patients to ingest [1.7.1].
  • Exservan: This is an oral film that dissolves on the tongue, offering another option for patients with swallowing issues [1.7.1, 1.4.5]. Its pricing is comparable to Tiglutik, with a supply of 60 films costing over $3,000 without insurance [1.2.4].

Comparison of Riluzole Formulations

Formulation Common Brand Name(s) Average Retail Price (Monthly, No Insurance) Key Feature
Oral Tablet Rilutek, Generic $966 (Brand) / ~$35 (Generic with coupon) [1.3.1] Most common and cost-effective form.
Oral Suspension Tiglutik ~$4,031 [1.4.2] Liquid form for patients with difficulty swallowing.
Oral Film Exservan ~$3,319 [1.2.4] Dissolvable film for easy administration.

Key Factors That Influence the Final Price

Several variables determine the final out-of-pocket cost for a patient [1.6.3, 1.6.4].

  • Insurance Coverage: This is the most significant factor. Most Medicare prescription drug plans cover generic riluzole, though it is often placed on a higher tier (Tier 4), meaning copays may still be considerable [1.9.1, 1.9.2]. Coverage for more expensive formulations like Tiglutik and Exservan can be more restrictive, sometimes requiring prior authorization to prove that the patient cannot take the tablet form [1.9.4, 1.9.5].
  • Pharmacy and Discount Cards: Prices for the same generic drug can vary by hundreds of dollars between pharmacies [1.2.1]. Using prescription discount cards like GoodRx can reduce the cost of generic riluzole by over 95% off the retail price [1.3.2].
  • Geographic Location: Drug prices can differ based on the state or even city where the pharmacy is located [1.6.5].

How to Reduce the Cost of Riluzole

Given the high costs, especially for newer formulations, several avenues for financial support exist.

  • Patient Assistance Programs (PAPs): Many pharmaceutical manufacturers offer PAPs to help uninsured or underinsured patients access their medications. Sanofi-Aventis, the maker of Rilutek, has a patient assistance program [1.5.4].
  • Non-Profit Organizations: Organizations like The ALS Association offer financial assistance grants that can help cover costs related to clinical care, which may include medication copays [1.10.1, 1.10.4]. Other foundations like the HealthWell Foundation and Patient Advocate Foundation also provide co-pay relief for ALS patients [1.5.2, 1.5.3].
  • Medicare and Medicaid: For eligible individuals, these government programs can significantly lower drug costs. All Medicare Part D plans cover generic riluzole, and patients may be eligible for Extra Help to reduce costs further [1.9.1, 1.5.5].

Conclusion

While the list price for riluzole, particularly its advanced formulations, can be prohibitively expensive, the actual cost to patients with ALS is highly variable. The introduction of generic riluzole tablets has made the standard treatment far more accessible, with prices under $40 a month possible with discount cards [1.2.2]. For those who require liquid or film versions due to swallowing difficulties, the cost is substantially higher, making insurance coverage and financial assistance programs essential. Patients and caregivers should actively explore insurance formularies, manufacturer PAPs, and non-profit grants to manage the financial burden of this vital medication.

For more information on financial support, consider visiting the The ALS Association [1.5.2].

Frequently Asked Questions

The average retail price can be over $900, but with a free prescription discount card, the cost can be as low as $23 to $35 for a one-month supply (60 tablets) [1.2.1, 1.3.1].

Yes, 100% of Medicare prescription drug (Part D) plans cover generic riluzole. However, it is typically placed on a higher tier (like Tier 4), which may result in a higher copay depending on your plan's coverage stage [1.9.1, 1.9.2].

Tiglutik (a liquid) and Exservan (a film) are newer, brand-name formulations designed for patients who have difficulty swallowing tablets [1.7.1, 1.4.5]. The higher cost reflects their status as specialty drugs and the lack of a generic equivalent for these forms [1.4.2, 1.2.4].

Rilutek is the original brand name for the riluzole tablet. Generic riluzole is the same active medication but is sold at a much lower price after the patent for Rilutek expired [1.3.1, 1.7.1]. They work the same way in the body.

You can seek help from Patient Assistance Programs (PAPs) offered by drug manufacturers, or apply for grants from non-profit organizations like The ALS Association, the HealthWell Foundation, and the Patient Advocate Foundation [1.5.4, 1.5.2, 1.10.1].

Their costs are in a similar high range. For a one-month supply without insurance, Exservan's price is around $3,300, while Tiglutik's can be around $4,000, though these prices can vary [1.2.4, 1.4.2].

No, riluzole does not cure ALS or reverse nerve damage that has already occurred. Its purpose is to slow the progression of the disease and prolong survival [1.7.2, 1.7.3].

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.